Pfizer Could Launch US Bevacizumab This Year Despite Patent Thicket

 
• By Aidan Fry
  
2019
Pfizer recently said it planned to launch biosimilar bevacizumab in the US this year, but several patents stand in the way • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products